Lineage Cell Therapeutics, Inc. (LCTX) › EPS (Basic)Lineage Cell Therapeutics, Inc. (LCTX) — EPS (Basic)Annual figures by period end, from SEC filings.2014-12-31: $-0.552015-12-31: $-0.592016-12-31: $0.352017-12-31: $-0.172021-12-31: $-0.262022-12-31: $-0.152023-12-31: $-0.122024-12-31: $-0.092025-12-31: $-0.28$-0.282014-12-31EPS (Basic) (USD/shares)2025-12-31Period endedEPS (Basic)Change YoYSource filing2025-12-31$-0.28—2026-03-05From 2025-01-012024-12-31$-0.09—2026-03-05From 2024-01-012023-12-31$-0.12—2025-03-10From 2023-01-012022-12-31$-0.15—2024-03-07From 2022-01-012021-12-31$-0.26—2023-03-09From 2021-01-012017-12-31$-0.17-148.6%2018-03-15From 2017-01-012016-12-31$0.35—2018-03-15From 2016-01-012015-12-31$-0.59—2018-03-15From 2015-01-012014-12-31$-0.55—2017-03-16From 2014-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares